Determinants of injectable depot medroxyprogesterone acetate contraception among women of reproductive age: A study from Southern Haryana, India
Introduction: The safety and effectiveness of Depot Medroxyprogesterone Acetate (DMPA) (available by the name of “Antara” in Government of India supply) has resulted in inclusion of this injectable contraceptive in the basket of family planning choices and thus has opened the way for clients to avai...
Main Authors: | Vikas Gupta, Suraj Chawla, Neeraj Gour, Pawan Kumar Goel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Community and Family Medicine |
Subjects: | |
Online Access: | http://www.ijcfm.org/article.asp?issn=2395-2113;year=2020;volume=6;issue=2;spage=144;epage=149;aulast=Gupta |
Similar Items
-
Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01) -
Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review
by: Adeniyi Kolade Aderoba, et al.
Published: (2023-07-01) -
New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes
by: Amanda Stang, et al.
Published: (2000-08-01) -
Depression and its correlates among geriatric people: A community based study from Southern Haryana, India
by: Suraj Chawla, et al.
Published: (2018-01-01) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022-01-01)